A Study Evaluating the Safety of the Nasal Pump

Clinical trial NCT06329687 · TERMINATED

Trial details

NCT number: NCT06329687
Sponsor: Oyster Point Pharma, Inc.
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Dry Eye Kerato Conjunctivitis Sicca

Start date: 2024-02-21
Primary completion: 2024-02-28
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.